Hypokalemia and hypomagnesaemia related to levetiracetam use     
Yazarlar (5)
Prof. Dr. Dürdane AKSOY Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Betül ÇEVİK Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Semiha Gülsüm Kurt
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Elmas Pekdaş
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Volkan Solmaz
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri)
Makale Alt Türü SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale
Dergi Adı JOURNAL OF CLINICAL NEUROSCIENCE
Dergi ISSN 0967-5868 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 11-2014
Cilt No 21
Sayı 11
Sayfalar 1989 / 1990
DOI Numarası 10.1016/j.jocn.2014.03.013
Makale Linki http://linkinghub.elsevier.com/retrieve/pii/S0967586814002203
Özet
Levetiracetam (LEV), used for both partial and generalized seizures, is a frequently preferred antiepileptic because of its few side effects. We present a 23-year-old man who developed hypokalemia after switching from valproate to LEV. The patient was sent to our clinic due to hypokalemia 1 month after initiation of LEV, and his neurological examination was normal. Further examinations revealed hypokalemia (3.1 mmol/L) and hypomagnesaemia (0.56 mmol/L). His hemogram, blood urea nitrogen, creatinine, total cortisol, thyroid function tests, creatinine clearance, and renal Doppler ultrasound were normal. LEV was tapered off and treatment with 200mg/day lamotrigine begun. Potassium and magnesium levels returned to normal ranges in subsequent tests. While hypokalemia and hypomagnesaemia have not been reported before to our knowledge, interstitial nephritis and renal failure after the use of LEV have been. Hypokalemia, found in the early period in this case, may be an indicator of a recently developed renal tubular disorder. This experience indicates that unpredictable side effects of increasingly used new antiepileptic drugs should be taken into consideration.
Anahtar Kelimeler
Epilepsy | Hypokalemia | Levetiracetam
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 10
Google Scholar 19
Hypokalemia and hypomagnesaemia related to levetiracetam use

Paylaş